Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More STEVEN GROSSMAN 5/10/18 STEVEN GROSSMAN 5/10/18 Alliance "Deeply Appreciative" of House's FY 19 Funding Mark Read More Analysis and Commentary STEVEN GROSSMAN 5/4/18 Analysis and Commentary STEVEN GROSSMAN 5/4/18 Additional Investment = Substantial Added Value Read More Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Alliance’s Advocacy Day a Success! Read More Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More Analysis and Commentary STEVEN GROSSMAN 4/13/18 Analysis and Commentary STEVEN GROSSMAN 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Notes from the Alliance’s Meeting with CBER Director Peter Marks and more Read More Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More STEVEN GROSSMAN 3/22/18 STEVEN GROSSMAN 3/22/18 Alliance Thanks Appropriators for Continued Support of FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More Advocacy at a Glance STEVEN GROSSMAN 3/11/18 Advocacy at a Glance STEVEN GROSSMAN 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More
STEVEN GROSSMAN 5/10/18 STEVEN GROSSMAN 5/10/18 Alliance "Deeply Appreciative" of House's FY 19 Funding Mark Read More
Analysis and Commentary STEVEN GROSSMAN 5/4/18 Analysis and Commentary STEVEN GROSSMAN 5/4/18 Additional Investment = Substantial Added Value Read More
Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More
Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More
Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Alliance’s Advocacy Day a Success! Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More
Analysis and Commentary STEVEN GROSSMAN 4/13/18 Analysis and Commentary STEVEN GROSSMAN 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More
Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Notes from the Alliance’s Meeting with CBER Director Peter Marks and more Read More
Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More
Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More
Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More
STEVEN GROSSMAN 3/22/18 STEVEN GROSSMAN 3/22/18 Alliance Thanks Appropriators for Continued Support of FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 3/11/18 Advocacy at a Glance STEVEN GROSSMAN 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More
